Literature DB >> 32957129

Monoplace chamber treatment of decompression illness: Review and commentary.

Richard Clarke1,2.   

Abstract

This paper summarises the history and capabilities of monoplace chambers in treatment of decompression illness (DCI); both in support of diving operations and in the hospital setting. In the field, monoplace hyperbaric chambers provide victims of DCI immediate access to recompression in settings where traditional multiplace chambers are not available. Alternatively, they may facilitate pressurised transport to a multiplace chamber for continued management. Recently, collapsible lightweight versions have improved suitability for field deployment aboard small vessels in remote settings, and for use by less technically capable military, occupational and civilian operators. The resulting elimination of treatment delays may prove lifesaving and central nervous system sparing, and avoid subsequent diving fitness disqualification. Monoplace chambers thus facilitate diving operations that would otherwise be difficult to condone on health and safety grounds. The 1960s saw the introduction of multiplace hyperbaric chambers into the hospital setting, as a number of non-diving conditions appeared to benefit from hyperbaric oxygen. This coincided with interest in hyperbaric oxygen as a solid tumour radiation sensitiser. Development of a novel acrylic-hulled single occupancy chamber enabled patients to undergo radiotherapy while pressurised within its oxygen atmosphere. Increasing numbers of health care facilities adopted this chamber type as a more economical, less complex alternative to the multiplace chamber. Incorporation of relevant biomedical technologies have allowed monoplace chambers to support increasingly complex patients in a safe, effective manner. Despite these advances, criticism of medical centre-based monoplace chamber treatment of DCI exists. This paper evaluates this controversy and presents relevant counter-arguments. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Cerebral arterial gas embolism; Decompression sickness; Diving medicine; Patient monitoring; Pressure chambers; Recompression

Mesh:

Year:  2020        PMID: 32957129      PMCID: PMC7755460          DOI: 10.28920/dhm50.3.264-272

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  26 in total

1.  High-pressure oxygen and radiotherapy.

Authors:  I CHURCHILL-DAVIDSON; C SANGER; R H THOMLINSON
Journal:  Lancet       Date:  1955-05-28       Impact factor: 79.321

2.  Radiobiologic basis of oxygen as a modifying factor in radiation therapy.

Authors:  L H GRAY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1961-05

3.  Efficient oxygen mask for patients undergoing hyperbaric oxygen therapy.

Authors:  P J Sheffield; R L Stork; T R Morgan
Journal:  Aviat Space Environ Med       Date:  1977-02

Review 4.  Operational use and patient care in the monoplace hyperbaric chamber.

Authors:  L K Weaver
Journal:  Respir Care Clin N Am       Date:  1999-03

5.  Health care worker decompression sickness: incidence, risk and mitigation.

Authors:  Richard Clarke
Journal:  Undersea Hyperb Med       Date:  2017 Nov-Dec       Impact factor: 0.698

6.  Hyperbaric treatment for decompression sickness: current recommendations.

Authors:  Richard E Moon; Simon Mitchell
Journal:  Undersea Hyperb Med       Date:  2019 Sep - Dec - Fourth Quarter       Impact factor: 0.698

7.  Cerebral arterial air embolism: I. Is there benefit in beginning HBO treatment at 6 bar?

Authors:  D R Leitch; L J Greenbaum; J M Hallenbeck
Journal:  Undersea Biomed Res       Date:  1984-09

Review 8.  A pro/con review comparing the use of mono- and multiplace hyperbaric chambers for critical care.

Authors:  Folke Lind
Journal:  Diving Hyperb Med       Date:  2015-03       Impact factor: 0.887

Review 9.  Medical devices and procedures in the hyperbaric chamber.

Authors:  Jacek Kot
Journal:  Diving Hyperb Med       Date:  2014-12       Impact factor: 0.887

10.  Monoplace hyperbaric chamber use of U.S. Navy Table 6: a 20-year experience.

Authors:  L K Weaver
Journal:  Undersea Hyperb Med       Date:  2006 Mar-Apr       Impact factor: 0.698

View more
  1 in total

1.  Oxygen toxicity seizures during United States Navy Treatment Table 6: An acceptable risk in monoplace chambers?

Authors:  Samantha Bonnington; Neil Banham; Kevin Foley; Ian Gawthrope
Journal:  Diving Hyperb Med       Date:  2021-06-30       Impact factor: 1.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.